Alastin Skincare Announces Issuance of Third U.S. Patent for TransFORM Body Treatment

This topical treatment helps to accelerate results and improve skintone and crepiness. Photo credit: Alastin Skincare (Photo credit: Alastin Skincare)

Alastin Skincare announced that the United States Patent and Trademark Office has issued a third U.S. Patent covering the company’s innovative science and products. U.S. Patent No. 10,493,011 is entitled, "Peptide Compositions and Methods for Ameliorating Skin Laxity and Body Contour."

This patent is directed to the composition and uses related to Alastin's breakthrough TransFORM Body Treatment, when used alone as well as when used in conjunction with body-shaping procedures. "With TransFORM Body Treatment, I am finally able to provide patients with a topical product that perfectly complements invasive and non-invasive fat reduction and body contouring procedures and energy-based body sculpting procedures by accelerating results as well as improving skintone and crepiness, ensuring patient's receive ideal post treatment outcomes," says Laurie Casas, M.D., clinical professor of surgery at the University of Chicago Medical Center and owner of Casas Aesthetic Plastic Surgery (Glenview, IL).     


Tribeca MedSpa to Open Second Location in New York City

AAFPRS President Offers Plastic Surgery Gifting Tips

ASDS Survey Reveals Interesting Findings